1. A randomized, phase IIa exploratory trial to assess the safety and preliminary efficacy of LEO 43204 in patients with actinic keratosis. (1st February 2016) Authors: Sinnya, S.; Tan, J.M.; Prow, T.W.; Primiero, C.; McEniery, E.; Selmer, J.; Østerdal, M.L.; Soyer, H.P. Journal: British journal of dermatology Issue: Volume 174:Number 2(2016) Page Start: 305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized, phase IIa exploratory trial to assess the safety and preliminary efficacy of LEO 43204 in patients with actinic keratosis. (9th January 2016) Authors: Sinnya, S.; Tan, J.M.; Prow, T.W.; Primiero, C.; McEniery, E.; Selmer, J.; Østerdal, M.L.; Soyer, H.P. Journal: British journal of dermatology Issue: Volume 174:Number 2(2016) Page Start: 305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗